Atossa Therapeutics
ATOS
$1.66
Share price
9.21%
Change (1 day)
151.52%
Change (1 year)
Categories
Number of shares outstanding for Atossa Therapeutics (ATOS)
Number of shares outstanding as of May 2024 : 125,793,000
According to Atossa Therapeutics's latest financial reports and stock price the company's current number of shares outstanding is 125,793,000. At the end of 2023 the company had 125,793,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Atossa Therapeutics from 2018 to 2023
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2023 | 0.12 B | -0.66% |
| 2022 | 0.12 B | 0.07% |
| 2021 | 0.12 B | 1145.11% |
| 2020 | 10.16 M | 11.31% |
| 2019 | 9.13 M | 76.14% |
| 2018 | 5.18 M |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 2,407,200,000 | 1,813.62% | 🇺🇸 USA |
 Quest Diagnostics
DGX | 111,000,000 | -11.76% | 🇺🇸 USA |
 LabCorp LH | 84,900,000 | -32.51% | 🇺🇸 USA |
 Translate Bio
TBIO.defunct | 62,908,800 | -49.99% | 🇺🇸 USA |
 NeoGenomics
NEO | 125,687,000 | -0.08% | 🇺🇸 USA |
 Enzo Biochem ENZ | 50,490,000 | -59.86% | 🇺🇸 USA |